Showing results (101-110 of 179) with videos related to
Sort By:
Pageof 18
Angewandte Chemie (International Ed. in English)|April 21, 2009
Synthesis of a chiral quaternary carbon center bearing a fluorine atom: enantio- and diastereoselective guanidine-catalyzed addition of fluorocarbon nucleophilesZhiyong Jiang, Yuanhang Pan, Yujun Zhao, et al.Gene|September 9, 2018
Overexpression and RNAi-mediated downregulation of TwIDI regulates triptolide and celastrol accumulation in Tripterygium wilfordiiJiadian Wang, Yujun Zhao, Yifeng Zhang, et al.European Journal of Medicinal Chemistry|April 21, 2023
Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell linesZiqin Yan, Xilin Lyu, Dongze Lin, et al.Journal of Medicinal Chemistry|January 13, 2025
Selective Degradation of TEADs by a PROTAC Molecule Exhibited Robust Anticancer Efficacy In Vitro and In VivoYuhang Lu, Ziqin Yan, Jiaqi Sun, et al.Frontiers in Oncology|July 12, 2021
Radiomics Analysis of Contrast-Enhanced CT Predicts Survival in Clear Cell Renal Cell CarcinomaLei Yan, Guangjie Yang, Jingjing Cui, et al.Journal of Medicinal Chemistry|December 8, 2023
Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor EfficacyJing Cheng, Ziqin Yan, Kailong Jiang, et al.European Journal of Medicinal Chemistry|August 29, 2019
Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteinsDeheng Chen, Tian Lu, Ziqin Yan, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2021
An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantationWenjie Miao, Pei Nie, Guangjie Yang, et al.International Journal of Clinical and Experimental Pathology|October 15, 2015
Prognostic significance of microRNA-203 in cholangiocarcinomaJingjing Li, Beibei Gao, Zufa Huang, et al.British Journal of Pharmacology|March 26, 2021
Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacyChenglong Liu, Feilong Zhou, Ziqin Yan, et al.Pageof 18